Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data.

Alison R McClean Michael R Law Mark Harrison Nick Bansback Tara Gomes Mina Tadrous

CMAJ

Centre for Health Services and Policy Research (McClean, Law) and Centre for Health Evaluation & Outcome Sciences (Bansback), School of Population and Public Health, University of British Columbia; British Columbia Centre for Excellence in HIV/AIDS (McClean); Faculty of Pharmaceutical Sciences (Harrison), University of British Columbia, Vancouver, BC; Li Ka Shing Knowledge Institute (Gomes), St. Michael's Hospital; Leslie Dan Faculty of Pharmacy (Gomes, Tadrous), University of Toronto; Women's College Research Institute (Tadrous), Women's College Hospital, Toronto, Ont.

Published: April 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035299	PMC
http://dx.doi.org/10.1503/cmaj.211478	DOI Listing

Publication Analysis

Top Keywords

uptake biosimilar

biosimilar drugs

drugs canada

canada analysis

analysis provincial

provincial policies

policies usage

usage data

uptake

drugs

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!